You can find the annual or quarterly income statement of Gain Therapeutics Inc here for insights into the performance and operational efficiency of Gain Therapeutics Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q2

FY2020Q1

Total revenue

----

--0.00

-100.00%0.00

--0.00

-100.00%0.00

22.61%55.18K

-100.00%0.00

6.65%95.10K

754.17%45.01K

--43.21K

--27.34K

1299.23%89.17K

-21.04%5.27K

--6.37K

--6.67K

Revenue

----

--0.00

-100.00%0.00

--0.00

-100.00%0.00

22.61%55.18K

-100.00%0.00

6.65%95.10K

754.17%45.01K

--43.21K

--27.34K

1299.23%89.17K

-21.04%5.27K

--6.37K

--6.67K

Operating expenses

34.07%4.47M

7.33%4.79M

-37.80%5.09M

-0.19%4.37M

-24.42%3.33M

-8.72%4.46M

5.84%8.18M

-17.17%4.38M

-3.38%4.41M

2.82%4.89M

46.66%7.73M

58.54%5.28M

40.26%4.56M

1.88%4.75M

46.28%5.27M

34.84%3.33M

--3.25M

--4.66M

568.80%3.60M

376.40%2.47M

--538.84K

--518.93K

R&D expenses

94.59%2.32M

8.71%2.81M

-38.17%2.72M

-10.04%2.22M

-49.86%1.19M

9.24%2.59M

10.40%4.40M

-11.47%2.47M

4.40%2.37M

20.50%2.37M

54.44%3.99M

79.33%2.79M

54.42%2.27M

-20.67%1.96M

43.98%2.58M

9.49%1.56M

--1.47M

--2.48M

308.67%1.79M

240.68%1.42M

--438.87K

--417.26K

Depreciation, depletion, and amortization

31.82%29.00K

0.00%22.00K

4.76%22.00K

0.64%20.66K

-6.74%22.00K

7.27%22.00K

3.76%21.00K

6.68%20.53K

30.25%23.59K

15.04%20.51K

1.09%20.24K

134.40%19.24K

212.89%18.11K

330.84%17.83K

827.76%20.02K

141.23%8.21K

--5.79K

--4.14K

-5.18%2.16K

61.97%3.40K

--2.28K

--2.10K

Operating profit

-34.07%-4.47M

-7.33%-4.79M

37.80%-5.09M

0.19%-4.37M

24.42%-3.33M

8.72%-4.46M

-5.84%-8.18M

16.29%-4.38M

3.38%-4.41M

-2.82%-4.89M

-49.35%-7.73M

-59.03%-5.23M

-42.15%-4.56M

-2.48%-4.75M

-47.28%-5.18M

-33.30%-3.29M

---3.21M

---4.64M

-560.06%-3.51M

-381.57%-2.47M

---532.47K

---512.26K

Net non-operating interest income (expenses)

Gains from sale of securities

-638.02%-84.78K

77.40%-27.38K

-1324.92%-620.92K

-137.52%-100.59K

103.86%15.76K

-247.37%-121.14K

27.61%-43.58K

725.73%268.08K

-105.34%-408.51K

89.00%82.20K

-249.69%-60.20K

-323.58%-42.84K

-911.13%-198.94K

258.66%43.49K

190.63%40.21K

3.36%19.16K

---19.68K

---27.41K

-813.55%-44.37K

126.90%18.54K

---4.86K

---68.91K

Income before tax

-36.89%-4.47M

-5.82%-4.74M

30.39%-5.67M

-10.90%-4.43M

30.70%-3.26M

4.73%-4.47M

-6.27%-8.14M

21.99%-3.99M

-2.46%-4.71M

-3.13%-4.70M

-50.93%-7.66M

-56.55%-5.12M

-42.38%-4.60M

2.24%-4.55M

-42.87%-5.08M

-33.67%-3.27M

---3.23M

---4.66M

-559.39%-3.55M

-319.78%-2.45M

---538.84K

---582.92K

Income tax

-86.11%70.12K

4896.25%549.29K

11579.49%141.21K

405.73%100.51K

3380.47%504.74K

-48.76%10.99K

-95.45%1.21K

18.81%19.87K

-81.43%14.50K

430.04%21.46K

190.72%26.59K

897.50%16.73K

1047.42%78.11K

-20.84%4.05K

149.89%9.15K

-51.80%1.68K

---8.24K

--5.11K

-19.08%3.66K

158.28%3.48K

--4.52K

--1.35K

Income after tax

-20.42%-4.54M

-17.81%-5.28M

28.66%-5.81M

-12.85%-4.53M

20.23%-3.77M

4.93%-4.49M

-5.92%-8.14M

21.86%-4.01M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-45.17%-4.67M

2.26%-4.56M

-42.98%-5.09M

-33.55%-3.27M

---3.22M

---4.66M

-554.57%-3.56M

-319.40%-2.45M

---543.36K

---584.27K

Net income from continuous operations

-20.42%-4.54M

-17.81%-5.28M

28.66%-5.81M

-12.85%-4.53M

20.23%-3.77M

4.93%-4.49M

-5.92%-8.14M

21.86%-4.01M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-45.17%-4.67M

2.26%-4.56M

-42.98%-5.09M

-33.55%-3.27M

---3.22M

---4.66M

-554.57%-3.56M

-319.40%-2.45M

---543.36K

---584.27K

Other net gains and losses

--3.51K

----

Net income attributable to controlling interests

-20.42%-4.54M

-17.81%-5.28M

28.66%-5.81M

-12.85%-4.53M

20.23%-3.77M

4.93%-4.49M

-5.92%-8.14M

21.86%-4.01M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-45.17%-4.67M

2.26%-4.56M

-42.98%-5.09M

-33.55%-3.27M

---3.22M

---4.66M

-554.57%-3.56M

-319.40%-2.45M

---543.36K

---584.27K

Net income attributable to common shareholders

-20.42%-4.54M

-17.81%-5.28M

28.66%-5.81M

-12.85%-4.53M

20.23%-3.77M

4.93%-4.49M

-5.92%-8.14M

21.86%-4.01M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-45.17%-4.67M

2.26%-4.56M

-42.98%-5.09M

-33.55%-3.27M

---3.22M

---4.66M

-554.57%-3.56M

-319.40%-2.45M

---543.36K

---584.27K

Basic earnings per share

11.79%-0.12

10.69%-0.15

54.82%-0.19

29.27%-0.16

56.76%-0.14

54.49%-0.17

31.72%-0.42

48.13%-0.22

20.04%-0.31

3.15%-0.37

-45.03%-0.62

-56.30%-0.43

-45.38%-0.39

2.31%-0.38

-42.90%-0.43

-33.48%-0.28

---0.27

---0.39

-524.55%-0.30

-300.17%-0.21

---0.05

Diluted earnings per share

11.79%-0.12

10.69%-0.15

54.82%-0.19

29.27%-0.16

56.76%-0.14

54.49%-0.17

31.72%-0.42

48.13%-0.22

20.04%-0.31

3.15%-0.37

-45.03%-0.62

-56.30%-0.43

-45.38%-0.39

2.31%-0.38

-42.90%-0.43

-33.48%-0.28

---0.27

---0.39

-524.55%-0.30

-300.17%-0.21

---0.05

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

